Palma Rocchi

Title: Palma Rocchi: Innovator in Cancer Treatment

Introduction

Palma Rocchi is a notable inventor based in Marseilles, France, recognized for his contributions to cancer research and treatment. With a total of five patents to his name, Rocchi has made significant strides in developing innovative therapies aimed at combating chemo- and hormone-resistant cancers.

Latest Patents

Rocchi's latest patents include groundbreaking inventions such as nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers. This invention focuses on a TCTP antagonist, specifically a nucleic acid that targets an mRNA encoding Translationally-Controlled Tumor Protein (TCTP). The nucleic acid is designed to reduce the amount of TCTP in cells, providing a potential treatment for hormone-independent cancers, including androgen-independent prostate cancer. Another significant patent involves hydrophobically modified antisense oligonucleotides comprising a triple alkyl chain. This invention concerns an oligonucleotide modified by substitution at the 3' or 5' end with a moiety that includes at least three hydrocarbon chains, which can be used as a medicament for treating cancer.

Career Highlights

Throughout his career, Palma Rocchi has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work in these organizations has contributed to advancements in medical research and the development of innovative cancer treatments.

Collaborations

Rocchi has collaborated with notable colleagues, including Julie Acunzo and Philippe Barthelemy, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Palma Rocchi's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His patents and collaborations reflect a commitment to improving patient outcomes in the fight against cancer.